Harbour Investments’s CONMED CNMD Stock Holding History

Harbour Investments’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-79	Closed	-$10K	–	2814
2021 Q3	$10K	Buy	79 +6	+8%	+$785	﹤0.01%	2651
2021 Q2	$10K	Buy	+73	New	+$9.99K	﹤0.01%	2708

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Harbour Investments's CNMD Position: Q4 2021 in Review

Harbour Investments sold out of CONMED (CNMD) in Q4 2021, closing a stake of 79 shares — an estimated $10K sold.

Harbour Investments first reported a position in CNMD in Q2 2021 and held it in 2 quarters. The position peaked at $10K in Q3 2021. 265 funds tracked by Wall St. Rank hold CNMD as of Q4 2021.

Harbour Investments reported no remaining CONMED position as of Q4 2021 after selling out during the quarter.
Harbour Investments sold 79 CONMED shares in Q4 2021, an estimated $10K.
Harbour Investments first reported a position in CONMED in Q2 2021 and held it in 2 quarters.
Harbour Investments's CONMED position peaked at $10K in Q3 2021.
265 funds tracked by Wall St. Rank held CONMED as of Q4 2021.

Based on Harbour Investments's 13F filing for Q4 2021, filed 16 Feb 2022.